140 related articles for article (PubMed ID: 10823402)
1. Effects of the non-competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward.
Tzchentke TM; Schmidt WJ
Psychopharmacology (Berl); 2000 Apr; 149(3):225-34. PubMed ID: 10823402
[TBL] [Abstract][Full Text] [Related]
2. Memantine does not substantially affect brain stimulation reward: comparison with MK-801.
Tzschentke TM; Schmidt WJ
Brain Res; 1999 Oct; 845(2):192-8. PubMed ID: 10536198
[TBL] [Abstract][Full Text] [Related]
3. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
4. Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801.
Carlezon WA; Wise RA
Brain Res; 1993 Aug; 620(2):339-42. PubMed ID: 8369967
[TBL] [Abstract][Full Text] [Related]
5. Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801-, but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm.
Tzschentke TM; Schmidt WJ
Behav Brain Res; 1998 Dec; 97(1-2):115-27. PubMed ID: 9867237
[TBL] [Abstract][Full Text] [Related]
6. Common influences of non-competitive NMDA receptor antagonists on the consolidation and reconsolidation of cocaine-cue memory.
Alaghband Y; Marshall JF
Psychopharmacology (Berl); 2013 Apr; 226(4):707-19. PubMed ID: 22829432
[TBL] [Abstract][Full Text] [Related]
7. Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats.
Hyytiä P; Bäckström P; Liljequist S
Eur J Pharmacol; 1999 Jul; 378(1):9-16. PubMed ID: 10478559
[TBL] [Abstract][Full Text] [Related]
8. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
9. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
10. Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice.
Belozertseva IV; Bespalov AYu
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):270-4. PubMed ID: 9750014
[TBL] [Abstract][Full Text] [Related]
11. Memantine and dizocilpine interactions with antinociceptive or discriminative stimulus effects of morphine in rats after acute or chronic treatment with morphine.
Chen Y; Evola M; Young AM
Psychopharmacology (Berl); 2013 Jan; 225(1):187-99. PubMed ID: 22864944
[TBL] [Abstract][Full Text] [Related]
12. Behavioral interactions caused by combined administration of morphine and MK-801 in rats.
Carlezon WA; Kosten TA; Nestler EJ
Psychopharmacology (Berl); 2000 Aug; 151(2-3):261-72. PubMed ID: 10972473
[TBL] [Abstract][Full Text] [Related]
13. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats.
Bespalov AY; Dravolina OA; Zvartau EE; Beardsley PM; Balster RL
Eur J Pharmacol; 2000 Mar; 390(3):303-11. PubMed ID: 10708738
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus.
Katsidoni V; Anagnostou I; Panagis G
Addict Biol; 2013 Mar; 18(2):286-96. PubMed ID: 22862835
[TBL] [Abstract][Full Text] [Related]
15. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
Popik P; Kozela E; Danysz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
[TBL] [Abstract][Full Text] [Related]
16. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal.
Maldonado C; Cauli O; Rodríguez-Arias M; Aguilar MA; Miñarro J
Behav Brain Res; 2003 Sep; 144(1-2):25-35. PubMed ID: 12946592
[TBL] [Abstract][Full Text] [Related]
17. Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward.
Panagis G; Kastellakis A; Spyraki C; Nomikos G
Psychopharmacology (Berl); 2000 May; 149(4):388-96. PubMed ID: 10867966
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
19. Reinstatement of morphine-conditioned reward is blocked by memantine.
Popik P; Wrobel M; Bisaga A
Neuropsychopharmacology; 2006 Jan; 31(1):160-70. PubMed ID: 15886718
[TBL] [Abstract][Full Text] [Related]
20. Retrieval-induced NMDA receptor-dependent Arc expression in two models of cocaine-cue memory.
Alaghband Y; O'Dell SJ; Azarnia S; Khalaj AJ; Guzowski JF; Marshall JF
Neurobiol Learn Mem; 2014 Dec; 116():79-89. PubMed ID: 25225165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
